Molulife 200 Capsule

Learn more about Molulife 200 Capsule, a quality offering from Mankind Pharma Ltd featuring the therapeutic benefits of Molnupiravir (200mg). This formulation is primarily utilized for Treatment of Mild to moderate Coronavirus disease (COVID-19). Browse through the detailed information provided below to enhance your knowledge about this medicine and its potential benefits for you.

MRP: ₹ 1399
Packing: 40.0 capsules in 1 bottle
Salt Combination: Molnupiravir (200mg)
Brand: Mankind Pharma Ltd
Uses: Treatment of Mild to moderate Coronavirus disease (COVID-19)

Description

Molulife 200 Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults
It prevents the virus from multiplying, thereby reducing viral load and disease severity
The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021
Molulife 200 Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms
The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases
It is not indicated in patients who require immediate hospitalization due to COVID-19
This drug has also been approved by the U.S
Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.Molulife 200 Capsule should be taken orally for no longer than 5 consecutive days
It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better
The medicine may cause dizziness, headache, diarrhea, and nausea in some patients
If one experiences any such side effects, discuss them with the doctor
They may help with the treatment or suggest ways to prevent them.
Before taking Molulife 200 Capsule, let the doctor know if you have any pre-existing medical conditions
To make sure it is safe for you, inform your doctor about all the other medications you are taking
The use of Molulife 200 Capsule is not recommended in pregnant women
Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Cautions

Liver:	SAFE IF PRESCRIBED: Molulife 200 Capsule is safe to use in patients with liver disease. No dose adjustment of Molulife 200 Capsule is recommended.
Kidney:	SAFE IF PRESCRIBED: Molulife 200 Capsule is safe to use in patients with kidney disease. No dose adjustment of Molulife 200 Capsule is recommended.
Driving:	CONSULT YOUR DOCTOR: It is not known whether Molulife 200 Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding:	UNSAFE: Molulife 200 Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Molulife 200 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Molulife 200 Capsule. Please consult your doctor.
Drug Action:	Antiviral (Non-HIV) drugs
Therapeutic class:	ANTI INFECTIVES
Habit Forming:	No
Chemical Class:	Cytosine Nucleotides

Uses of Molulife 200 Capsule

In Treatment of Mild to moderate Coronavirus disease (COVID-19) Molulife 200 Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration
This medicine may help you recover from the infection if diagnosed early before hospitalization
If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.